MedaSystems 3/19/25 MedaSystems 3/19/25

MedaSystems Launches Major New Product Release to Accelerate Automation, Configurability, and Security Requirements for its Global Customers

MedaSystems 3/5/25 MedaSystems 3/5/25

MedaSystems Secures Additional Seed Financing to Advance Its AI-Driven Workflow Platform for Expanded Access and Investigator-Initiated Studies

MedaSystems 12/4/24 MedaSystems 12/4/24

MedaSystems Appoints Healthcare Technology Leader Brian Irwin to Spearhead Next Stage of Growth

BRIAN IRWIN Brian is a strategic leader with 25 years of driving exceptional growth as an Operator, Executive, Investor, and Entrepreneur in the Healthcare and Life Sciences industries. His expertise lies in SaaS technology

Guest User 1/9/24 Guest User 1/9/24

Debiopharm Innovation Fund invests in MedaSystems

We are pleased to announce additional funding from Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, motivated by their vision of patient centric, data-enabled clinical research and enabling patients to access novel treatments sooner.

Guest User 10/12/23 Guest User 10/12/23

MedaSystems closes Seed Funding

We’re very pleased to share with you that MedaSystems has closed a seed funding round, in order to continue to grow our market and further build out the platform.

Matthew Rosen 10/5/23 Matthew Rosen 10/5/23

MedaSystems Demonstrates Continued Commitment to Protecting Expanded Access Data with Successful SOC 2 Type 2 Audit

We are thrilled to announce the successful completion of a Service Organization Control (SOC) 2 Type 2 audit. As industry leaders in the SaaS Expanded Access software sector, this accomplishment underscores our unwavering commitment to data security, patient privacy, and regulatory compliance.

Guest User 9/28/23 Guest User 9/28/23

Young Sohn joins MedaSystems’ advisory board

Industry veteran, Young Sohn, joins the advisory board of MedaSystems.

Matthew Rosen 1/24/23 Matthew Rosen 1/24/23

MedaSystems receives SOC 2 Type 1 certification

We are pleased to share that we’ve been SOC2 Type 1 certified.

Guest User 12/14/22 Guest User 12/14/22

MedaSystems welcomes Dr. Jean Godin as advisor

Dr. Jean Godin joins MedaSystems as a strategic advisor.

Guest User 11/11/22 Guest User 11/11/22

MedaSystems welcomes Lisa Suennen to board of advisors

We’re thrilled to announce that Lisa Suennen has joined our board of advisors. Ms. Suennen is the President of Digital and Data Solutions at Canary Medical. She brings her deep expertise in digital health, technology, and life sciences to bear on MedaSystems’ mission to help life science companies collaborate with physicians and their patients seeking early access to investigational medicines.